The health care sector was Friday's best performer, as drug stocks got a lift after reports that Senate Republican leaders said thedrug-pricing proposal unveiled by House Speaker Nancy Pelosi and other top Democrats would be dead on arrival. The SPDR Health Care Select Sector ETF rose 0.9% with 56 of 62 components gaining ground, to pace the gainers of the SPDR ETFs tracking the S&P 500's 11 key sectors. In addition, the top 3 gainers among the Dow Jones Industrial Average components were in the drug business, as shares of Walgreens Boots Alliance Inc. gained 2.2%, Merck & Co. Inc. tacked on 1.8% and Johnson & Johnson advanced 1.3%. Also in the Dow, shares of Pfizer Inc. rose 0.8% and UnitedHealth Group Inc. gained 0.5%. The Democrats's Lower Drug Costs Now Act would have the government negotiate prices for the 25 most expensive drugs each year, while Republicans criticized the proposal as a "socialist approach."